Paper17524101
Transfusion premedications: a growing practice not based on evidence.
Tobian AA and 2 others. Transfusion, 2007. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Transfusion premedications: a growing practice not based on evidence. Papers, record 17524101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17524101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocyte Transfusion | Major topic |
| Hypersensitivity | Major topic |
| Leukocyte Reduction Procedures | Major topic |
| Platelet Transfusion | Major topic |
| Premedication | Major topic |
| Blood Group Incompatibility | |
| Evidence-Based Medicine | |
| History, 20th Century | |
| Humans | |
| Incidence | |
| Institutional Practice | |
| Respiratory Distress Syndrome | |
| Sepsis |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936835 | Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges. | Matern Fetal Med | 2026 | https://conductscience.org/library/papers/42936835 | PubMed |
| 40681467 | Transfusion strategies in thalassemia and sickle cell disease SITE-SIMTI-SIdEM Good Practice. | Blood Transfus | 2025 | https://conductscience.org/library/papers/40681467 | PubMed |
| 35720859 | Improving Blood Product Transfusion Premedication Plan Documentation: A Single-institution Quality Improvement Effort. | Pediatr Qual Saf | 2022 | https://conductscience.org/library/papers/35720859 | PubMed |
| 34453453 | The transfusion management of beta thalassemia in the United States. | Transfusion | 2021 | https://conductscience.org/library/papers/34453453 | PubMed |
| 31914091 | Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/31914091 | PubMed |
| 28090496 | Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan. | Blood Res | 2016 | https://conductscience.org/library/papers/28090496 | PubMed |
| 27079627 | Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions. | Transfusion | 2016 | https://conductscience.org/library/papers/27079627 | PubMed |
| 25209730 | Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets. | Transfusion | 2015 | https://conductscience.org/library/papers/25209730 | PubMed |
| 25065959 | Transfusion-related adverse events in the Platelet Dose study. | Transfusion | 2015 | https://conductscience.org/library/papers/25065959 | PubMed |
| 24517134 | Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets. | Transfusion | 2014 | https://conductscience.org/library/papers/24517134 | PubMed |
| 24251374 | The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME). | Transfusion | 2014 | https://conductscience.org/library/papers/24251374 | PubMed |
| 23363552 | The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions. | Transfusion | 2013 | https://conductscience.org/library/papers/23363552 | PubMed |
| 22998777 | Scratching the surface of allergic transfusion reactions. | Transfusion | 2013 | https://conductscience.org/library/papers/22998777 | PubMed |
| 22233358 | The impact of apheresis platelet manipulation on corrected count increment. | Transfusion | 2012 | https://conductscience.org/library/papers/22233358 | PubMed |
| 21883267 | Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. | Transfusion | 2012 | https://conductscience.org/library/papers/21883267 | PubMed |
| 21569041 | Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets. | Transfusion | 2011 | https://conductscience.org/library/papers/21569041 | PubMed |
| 21214586 | Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. | Transfusion | 2011 | https://conductscience.org/library/papers/21214586 | PubMed |
| 20556779 | Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20556779 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17524101
GET https://conductscience.org/api/papers/v1/17524101/authors